PharmEasy devaluation: Thyrocare founder invokes anti-diluti

Happy Friday! Arokiaswamy Velumani, founder of Thyrocare, which was acquired by PharmEasy in 2021, had secured anti-dilution rights when he invested in the epharmacy startup. We have details on that, and more in todays ETtech Morning Dispatch.

Related Keywords

Somnath , Gujarat , India , Brazil , Ajay Goel , Byju Raveendran , Arokiaswamy Velumani , Prashant Jhaveri , Whitehat Jr , Kanchan Mishra , Pawan Goenka , Facebook , Supreme Court , Authorization Center , Competition Commission Of India , Flipkart Health , Apollo Health , Board Advisory Committee , Indian National Space Promotion , Walmart , Instagram , Twitter , Google , Inside Paytm , General Atlantic , Paytm Postpaid , Space Foreign Direct Investment , Will Indian , Competition Commission , Give Every ,